FDA Poised to Ban Menthol Cigarettes
THURSDAY, April 29, 2021 (HealthDay News) — The U.S. Food and Drug Administration on...
Read More
Hematology/Oncology
White House to Propose Menthol Cigarette Ban
WEDNESDAY, April 28, 2021 (HealthDay News) — A proposed ban on menthol cigarettes is...
Read More
PAX8 and MECOM are interaction partners driving ovarian cancer.
The transcription factor PAX8 is critical for the development of the thyroid and urogenital...
Read More
IGF-1R anti-idiotypic antibody antagonist exhibited anti-ovarian cancer bioactivity and reduced cisplatin resistance.
Ovarian cancer is the most deadly gynecological malignant tumor in the world today. Previous...
Read More
Development of a high payload, cancer-targeting liposomes of methyl aminolevulinate for intraoperative photodynamic diagnosis/therapy of peritoneal carcinomatosis.
Methyl aminolevulinate (MAL) is a photosensitizer topically used for photodynamic diagnosis (PDD)...
Read More
Exposure to Secondhand Smoke May Raise Risk for Oral Cancer
WEDNESDAY, April 28, 2021 (HealthDay News) — There seems to be a causal association between...
Read More
Increasing BMI Ups Risk for Second Cancer After Breast Cancer
TUESDAY, April 27, 2021 (HealthDay News) — For women with incident breast cancer, the risk...
Read More
Carboplatin Alone Not Adequate for Ovarian Cancer in Frail Seniors
TUESDAY, April 27, 2021 (HealthDay News) — For vulnerable older patients with ovarian...
Read More
VTE Risk High in Cancer Patients Receiving Immune Checkpoint Inhibitors
MONDAY, April 26, 2021 (HealthDay News) — Patients with cancer receiving immune checkpoint...
Read More
Steroids Unrelated to Psychological Reactions in Pediatric ALL
MONDAY, April 26, 2021 (HealthDay News) — For children with acute lymphoblastic leukemia...
Read More
Female Sex, Work Culture Biggest Contributors to Physician Burnout
MONDAY, April 26, 2021 (HealthDay News) — Clinician sex and local work culture may...
Read More
Lower Incomes Increase Cancer Worry, Anxiety During Pandemic
MONDAY, April 26, 2021 (HealthDay News) — Lower annual income is associated with increased...
Read More
AHA Offers Guidance for CVD Risk in Breast, Prostate Cancer
MONDAY, April 26, 2021 (HealthDay News) — In a scientific statement issued by the American...
Read More
COVID-19 Vaccinations Now Mandatory for Houston Methodist Hospital Workers
MONDAY, April 26, 2021 (HealthDay News) — All 26,000 Houston Methodist workers must get a...
Read More
FDA Holds Meeting to Review Merits of Approved Cancer Drugs
MONDAY, April 26, 2021 (HealthDay News) — For the first time in a decade, the U.S. Food and...
Read More
FDA Approves Immunotherapy for dMMR Endometrial Cancer
FRIDAY, April 23, 2021 (HealthDay News) — The anti-programmed death receptor 1 (PD-1)...
Read More
FDA Moves to Resume Use of J&J COVID Vaccine
FRIDAY, April 23, 2021 (HealthDay News) — The U.S. Food and Drug Administration on Friday...
Read More
A Population Pharmacokinetic Meta-analysis of Veliparib, a PARP Inhibitor, Across Phase I/II/III Trials in Cancer Patients.
Veliparib (ABT-888) is a poly (ADP-ribose) polymerase (PARP) inhibitor in development for...
Read More
Oleuropein reduces cisplatin resistance in ovarian cancer by targeting apoptotic pathway regulators.
Despite many attempts to treat ovarian cancer, 13,940 individuals perish annually due to this...
Read More
Circular RNA circE2F2 promotes malignant progression of ovarian cancer cells by upregulating the expression of E2F2 protein via binding to HuR protein.
Ovarian cancer (OC) is a gynecological malignancy with a poor prognosis and low survival rate....
Read More